Notably, IL-18 been reported to act synergistically with other pro-inflammatory cytokines to promote antitumor immune responses and potentiate the effects of ICIs, and lower levels of G-CSF are associated with a less immunosuppressive tumor immune microenvironment39–41. The gene discussed is IL18; the disease is neoplasm.